Excerpt

This guideline aims to: identify and describe best practice for service organisation and delivery that will improve access, acceptability and use of services; identify and describe services that encourage, overcome barriers to and facilitate the maintenance of contact throughout pregnancy; describe additional consultations with and/or support and information for women with complex social factors, and their partners and families, that should be provided during pregnancy, over and above that described in the NICE guideline ‘Antenatal care: routine care for the healthy pregnant woman’ (2008) (clinical guideline 62); identify when additional midwifery care or referral to other members of the maternity team (obstetricians and other specialists) would be appropriate, and what that additional care should be.

Contents

• Guideline Development Group membership and acknowledgements
• 1. Guidance summary
  • 1.1 Key priorities for implementation
  • 1.2 Recommendations
  • 1.3 Research recommendations
  • 1.4 Service model
• 2. Introduction
  • 2.1 Pregnant women with complex social factors: a model for service provision
  • 2.2 Aim and scope of the guideline
  • 2.3 Abbreviations and glossary
  • 2.4 For whom is the guidance intended?
  • 2.5 Other relevant documents
  • 2.6 Who has developed the guidance?
  • 2.7 Guideline development methodology
  • 2.8 Schedule for updating the guidance
• 3. Overarching principles
  • 3.1 Introduction
  • 3.2 Access to care
  • 3.3 General principles of care
  • 3.4 Recommendations
  • 3.5 Research recommendations
• 4. Women who misuse substances
  • 4.1 Introduction
  • 4.2 Access to antenatal services
  • 4.3 Barriers to care
  • 4.4 Maintaining contact
  • 4.5 Additional consultations and support
  • 4.6 Additional information
  • 4.7 Health economic considerations
  • 4.8 Recommendations
• 5. Women who are recent migrants, asylum seekers or refugees, and women who have difficulty reading or speaking English
  • 5.1 Introduction
  • 5.2 Access to antenatal services
  • 5.3 Barriers to care
  • 5.4 Maintaining contact
  • 5.5 Additional consultations and support
  • 5.6 Additional information
  • 5.7 Recommendations
• 6. Young women aged under 20
  • 6.1 Introduction
  • 6.2 Access to antenatal services
  • 6.3 Barriers to care
  • 6.4 Maintaining contact
  • 6.5 Additional consultations
  • 6.6 Additional information
  • 6.7 Health economics considerations
  • 6.8 Recommendations
• 7. Women who experience domestic abuse
  • 7.1 Introduction
  • 7.2 Access to antenatal services
  • 7.3 Barriers to care
  • 7.4 Maintaining contact
  • 7.5 Additional consultations
  • 7.6 Additional information
  • 7.7 Health economic considerations
  • 7.8 Recommendations
• 8. Health economics
  • 8.1 Cost effectiveness question
• Appendix A Scope
• Appendix B Declarations of interest
• Appendix C Registered stakeholder organisations
• Appendix D Service descriptions
• Appendix E Evidence tables
• Appendix F Excluded studies
• Appendix G Search strategies
• Appendix H PICO tables
• References

While every effort has been made to ensure the accuracy of the information contained within this publication, the publisher can give no guarantee for information about drug dosage and application thereof contained in this book. In every individual case the respective user must check current indications and accuracy by consulting other pharmaceutical literature and following the guidelines laid down by the manufacturers of specific products and the relevant authorities in the country in which they are practising.

This guideline has been fully funded by NICE. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual woman.

Implementation of this guidance is the responsibility of local commissioners and/or providers.